RF Micro (RFMD): Upgraded to Buy at UBS, ests upped significantly
Get Alerts RFMD Hot Sheet
Rating Summary:
12 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
From Notable Calls
UBS is out with a major call on RF Micro (NASDAQ: RFMD) upgrading the stock to a Buy with a $3 tgt.
The firm upgrades RFMD to Buy from Neutral for the following reasons: 1) They significantly raise estimates as recent checks show strengthening momentum 2) With major restructuring measures complete, RFMD is likely to see sizeable margin expansion due to increased utilization, and 3) They expect more positive action to reduce debt burden. Upgrade to Buy & raise PT to $3, equal to P/S of ~1.
March marks the trough in fundamentals; Multiple drivers going forward
Checks confirm that March was the tough, and strong momentum during the current restocking phase could support a high single digit (possibly low double digit) sequential growth in June qtr, compared to consensus view of +3% seq for June. Also, impact from recent restructuring should also contribute towards higher margins. UBS further believes that company’s new product initiatives aimed at reducing die size should also contribute towards higher revenue and margins.
Raising estimates significantly above consensus
Based on their positive view for the sector and improving outlook for RFMD, they are significantly raising our estimates. For FY10, they are modelling pro forma Rev/EPS of $798m/$0.08 (cons $743m/-$0.04), up from $721m/$0.02. For FY11, they are forecasting pro forma Rev/EPS of $886m/$0.16 (cons $812m/$0.00), up from $802m/$0.11.
Notablecalls: I think this one can do $2+ in this market. UBS has done some digging and the numbers they have published today are BIG.
Stocks with similar charts (for example Ruby (RT) ) have done pretty well lately in reaction to upgrades.
For more calls go here http://notablecalls.blogspot.com/
You May Also Be Interested In
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
- enVVeno Medical (NVNO) files $100M mixed shelf
Create E-mail Alert Related Categories
Contributors, UpgradesRelated Entities
UBS, Notable CallsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share